Clinical trial
Dual Release Gastric Retentive AP09004, Vs. Active Control; a Pharmacokinetic/Pharmacodynamic, Comparative, Safety Evaluation in Parkinson's Patients
NCT00918177 is registered in ClinicalTrials.gov with Intec Pharma Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dual Release Gastric Retentive AP09004, Vs. Active Control; a Pharmacokinetic/Pharmacodynamic, Comparative, Safety Evaluation in Parkinson's Patients
- Lead sponsor
- Intec Pharma Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- Not reported
- Enrollment
- 72 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease